Professor Michael Hofman is a Nuclear Medicine Physician and leads the Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC) at Peter MacCallum Cancer Centre. He was elected a Fellow of the Academy in 2023 and presented at our Annual Meeting on his ground-breaking research in PSMA PET and PSMA radioligand therapy which has revolutionised prostate cancer imaging and treatment.
